Anterix (ATEX) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to -$0.35.
- Anterix's EPS (Basic) fell 18536.59% to -$0.35 in Q4 2025 from the same period last year, while for Dec 2025 it was $4.36, marking a year-over-year increase of 36748.47%. This contributed to the annual value of -$0.61 for FY2025, which is 2594.44% down from last year.
- Latest data reveals that Anterix reported EPS (Basic) of -$0.35 as of Q4 2025, which was down 18536.59% from $2.86 recorded in Q3 2025.
- Over the past 5 years, Anterix's EPS (Basic) peaked at $2.86 during Q3 2025, and registered a low of -$0.84 during Q2 2024.
- Moreover, its 5-year median value for EPS (Basic) was -$0.38 (2022), whereas its average is -$0.04.
- Over the last 5 years, Anterix's EPS (Basic) had its largest YoY gain of 225730.9% in 2024, and its largest YoY loss of 72727.27% in 2024.
- Over the past 5 years, Anterix's EPS (Basic) (Quarter) stood at -$0.69 in 2021, then surged by 39.13% to -$0.42 in 2022, then soared by 104.14% to $0.02 in 2023, then soared by 2257.31% to $0.41 in 2024, then plummeted by 185.37% to -$0.35 in 2025.
- Its EPS (Basic) stands at -$0.35 for Q4 2025, versus $2.86 for Q3 2025 and $1.35 for Q2 2025.